# Clinical Efficacy And Safety of Dydrogesterone In The Treatment Of Abnormal Uterine Bleeding During Puberty

> **NCT07703488** · — · RECRUITING · sponsor: **Guangdong Women and Children Hospital** · enrollment: 240 (estimated)

## Conditions studied

- Abnormal Uterine Bleeding (AUB)
- Ovulation Dysfunction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07703488
- **Lead sponsor:** Guangdong Women and Children Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-06
- **Primary completion:** 2028-03-28
- **Final completion:** 2028-07-28
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703488, "Clinical Efficacy And Safety of Dydrogesterone In The Treatment Of Abnormal Uterine Bleeding During Puberty". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07703488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*